scispace - formally typeset
K

Kyriakos Neofytou

Researcher at The Royal Marsden NHS Foundation Trust

Publications -  32
Citations -  448

Kyriakos Neofytou is an academic researcher from The Royal Marsden NHS Foundation Trust. The author has contributed to research in topics: Hepatectomy & Renal cell carcinoma. The author has an hindex of 11, co-authored 32 publications receiving 369 citations. Previous affiliations of Kyriakos Neofytou include National and Kapodistrian University of Athens & Nicosia General Hospital.

Papers
More filters
Journal ArticleDOI

Elevated platelet to lymphocyte ratio predicts poor prognosis after hepatectomy for liver-only colorectal metastases, and it is superior to neutrophil to lymphocyte ratio as an adverse prognostic factor

TL;DR: It is indicated that preoperative PLR is superior to preoperative NLR as an adverse prognostic factor in patients who undergo liver resection for liver-only colorectal metastases.
Journal ArticleDOI

The Preoperative Lymphocyte-to-Monocyte Ratio is Prognostic of Clinical Outcomes for Patients with Liver-Only Colorectal Metastases in the Neoadjuvant Setting

TL;DR: Preoperative LMR is identified as an independent prognostic factor for PRS, CSS, and OS but not for DFS in patients undergoing hepatectomy for liver-only colorectal metastases, and interventions to augment immune function could improve survival for low-LMR patients.
Journal ArticleDOI

Early or Delayed Intervention for Bile Duct Injuries following Laparoscopic Cholecystectomy? A Dilemma Looking for an Answer

TL;DR: Early repair after BDI results in equal outcomes compared with late repairs when performed by specialists, and BDI patients should be referred to centers of expertise and experience.
Journal ArticleDOI

Prognostic impact of preoperative platelets to lymphocytes ratio (PLR) on survival for oesophageal and junctional carcinoma treated with neoadjuvant chemotherapy: A retrospective monocentric study on 153 patients.

TL;DR: It is demonstrated that elevated PLR is associated with poor OS and DFS for OJA treated with a curative intent and has the potential to be a useful prognostic biomarker for treatment planning.